← Leaderboards
Elena Martinez Stoffel
Georgetown University
$3,462,573
Attributed
$8,882,182
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,882,182 · 4
By mechanism
R01$4,173,878 · 2
U01$3,955,535 · 1
K07$752,769 · 1
Top collaborators
- Kristen S. Purrington7 shared
- Laura Rozek7 shared
- Fay Kastrinos2 shared
- Sonia Kupfer2 shared
- Jennifer J Griggs1 shared
- Ken A. Resnicow1 shared
Most similar at Georgetown University
Same institution · by research overlap
- Alejandra Hurtado De Mendoza Casaus$3,088,220
- Laura Rozek$5,698,652
- Kristen S. Purrington$1,950,995
- Chiranjeev Dash$2,096,750
- Robert R. Clarke$13,679,896
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsColorectal CancerCharacteristicsCohortMutationGeneticGene MutationBehavioralPhenotypeHigh RiskEarly DiagnosisMismatch RepairGenesInheritedPopulation HeterogeneityColorectal Cancer RiskComplementIncidenceScreening For CancerGeographyHereditary Nonpolyposis Colorectal NeoplasmsOperative Surgical ProceduresReportingUnited States
Grant awards (17)
FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trial$669,912
R01 · FY2025 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$634,182
R01 · FY2025 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$182,047
R01 · FY2025 · CA
FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trial$701,911
R01 · FY2024 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$560,797
R01 · FY2024 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$154,306
R01 · FY2024 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$615,500
R01 · FY2022 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$1
R01 · FY2022 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$655,222
R01 · FY2021 · CA
Innovative Approaches to Expand Cancer Genetic Screening and Testing for Patients & Families in a Statewide Oncology Network through Community, State, & Payer Partnerships$3,955,535
U01 · FY2020 · CA · contact PI
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes$101,586
K07 · FY2011 · CA · contact PI
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes$39,962
K07 · FY2011 · CA · contact PI
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes$141,548
K07 · FY2010 · CA · contact PI
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes$141,548
K07 · FY2009 · CA · contact PI
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes$45,335
K07 · FY2009 · CA · contact PI
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes$141,548
K07 · FY2008 · CA · contact PI
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes$141,242
K07 · FY2007 · CA · contact PI